TABLE OF CONTENTS
|  |  |  | Volume 33, Issue 20 (May 2014) |  | In this issue Review Original Articles Short Communication
Also new    AOP | |  |  | Review | Top |  | Rare insights into cancer biologyJ Adam, M Yang, T Soga and P J Pollard Oncogene 2014 33: 2547-2556; advance online publication, July 1, 2013; 10.1038/onc.2013.222 Abstract | Full Text |  | Original Articles | Top |  | MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinomaH J Bae, J H Noh, J K Kim, J W Eun, K H Jung, M G Kim, Y G Chang, Q Shen, S-J Kim, W S Park, J Y Lee and S W Nam Oncogene 2014 33: 2557-2567; advance online publication, June 3, 2013; 10.1038/onc.2013.216 Abstract | Full Text |  |  |  | PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsA I Velghe, S Van Cauwenberghe, A A Polyansky, D Chand, C P Montano-Almendras, S Charni, B Hallberg, A Essaghir and J-B Demoulin Oncogene 2014 33: 2568-2576; advance online publication, June 10, 2013; 10.1038/onc.2013.218 Abstract | Full Text |  |  |  | Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanomaC C Jiang, A Croft, H-Y Tseng, S T Guo, L Jin, P Hersey and X D Zhang Oncogene 2014 33: 2577-2588; advance online publication, June 17, 2013; 10.1038/onc.2013.237 Abstract | Full Text |  |  |  | Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancerQ Li, Y Yao, G Eades, Z Liu, Y Zhang and Q Zhou Oncogene 2014 33: 2589-2600; advance online publication, June 10, 2013; 10.1038/onc.2013.226 Abstract | Full Text |  |  |  | RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastomaF Yu, W Gao, T Yokochi, Y Suenaga, K Ando, M Ohira, Y Nakamura and A Nakagawara Oncogene 2014 33: 2601-2609; advance online publication, July 15, 2013; 10.1038/onc.2013.221 Abstract | Full Text |  |  |  | Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formationM de Graauw, L Cao, L Winkel, M H A M van Miltenburg, S E le Dévédec, M Klop, K Yan, C Pont, V-M Rogkoti, A Tijsma, A Chaudhuri, R Lalai, L Price, F Verbeek and B van de Water Oncogene 2014 33: 2610-2619; advance online publication, June 24, 2013; 10.1038/onc.2013.219 Abstract | Full Text |  |  |  | Loss of N-Myc interactor promotes epithelial–mesenchymal transition by activation of TGF-β/SMAD signalingD J Devine, J W Rostas, B J Metge, S Das, M S Mulekar, J A Tucker, W E Grizzle, D J Buchsbaum, L A Shevde and R S Samant Oncogene 2014 33: 2620-2628; advance online publication, June 17, 2013; 10.1038/onc.2013.215 Abstract | Full Text |  |  |  | miR-27a regulates endothelial differentiation of breast cancer stem like cellsW Tang, F Yu, H Yao, X Cui, Y Jiao, L Lin, J Chen, D Yin, E Song and Q Liu Oncogene 2014 33: 2629-2638; advance online publication, June 10, 2013; 10.1038/onc.2013.214 Abstract | Full Text |  |  |  | Utility of a bacterial infection model to study epithelial–mesenchymal transition, mesenchymal–epithelial transition or tumorigenesisP Chandrakesan, B Roy, L U M R Jakkula, I Ahmed, P Ramamoorthy, O Tawfik, R Papineni, C Houchen, S Anant and S Umar Oncogene 2014 33: 2639-2654; advance online publication, June 10, 2013; 10.1038/onc.2013.210 Abstract | Full Text |  |  |  | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasisX Lu, S J Mazur, T Lin, E Appella and Y Xu Oncogene 2014 33: 2655-2664; advance online publication, June 17, 2013; 10.1038/onc.2013.209 Abstract | Full Text |  |  |  | ARF inhibits the growth and malignant progression of non-small-cell lung carcinomaS E Busch, R D Moser, K E Gurley, K S Kelly-Spratt, H D Liggitt and C J Kemp Oncogene 2014 33: 2665-2673; advance online publication, June 10, 2013; 10.1038/onc.2013.208 Abstract | Full Text |  | Short Communication | Top |  | Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinomaZ J Li, S C Mack, T H Mak, S Angers, M D Taylor and C-C Hui Oncogene 2014 33: 2674-2680; advance online publication, June 10, 2013; 10.1038/onc.2013.212 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment
Keep a civil tongue.